Drugs / protein vaccine boost
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00061243 | Apr 2004 → Apr 2005 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | protein vaccine boost | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00061243 ↗ |
| Modality | Vaccine | “The first vaccine component administered in this study is a DNA vaccination; the second component is a recombinant protein vaccination.” NCT00061243 ↗ |